Saturday, July 11, 2026

Drug profile · INN

protocol

protocol is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 16
Pipeline programs 59
News articles 0
Drug details — protocol
Class
Route
Patents
16
Programs
59
Data quality
0.70

Quick answer

protocol is an FDA-listed pharmaceutical active ingredient.

Key facts

INN protocol

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. 12-Valent Pneumococcal Conjugate Vaccine Phase 3 · MAIA Biotechnology · Pneumococcal Vaccines
  2. 2-mg Intravitreous Aflibercept Injection Phase 3 · Regeneron UK · Proliferative Diabetic Retinopathy
  3. 2.0 mg intravitreal aflibercept Phase 3 · Regeneron UK · Diabetic Macular Edema
  4. 5-Fu/epirubicin/CTX following Docetaxel Phase 3 · Chinese Academy of · Breast Cancer
  5. Coronary CTA Phase 3 · Chinese Academy of · Coronary Artery Disease
  6. Prompt aflibercept Phase 3 · Regeneron UK · Diabetic Macular Edema
  7. Prompt aflibercept Phase 3 · Regeneron UK · Diabetic Retinopathy
  8. RBC transfusion based on different protocols Phase 3 · Chinese Academy of · Transfusion Related Complication

Related patents

  1. US 11858931

    Amino acid compounds with unbranched linkers and methods of use

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 11745026

    Laser assisted wound healing protocol and system

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 11730760

    Laser assisted wound healing protocol and system

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 11684797

    Laser assisted wound healing protocol and system

    Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 11673887

    N-acyl amino acid compounds and methods of use

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 11654293

    Laser assisted wound healing protocol and system

    Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 11634418

    Amino acid compounds and methods of use

    Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 11622991

    Protocol for treatment of lupus nephritis

    Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 11560376

    Amino acid compounds and methods of use

    Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 11396506

    Amino acid compounds with unbranched linkers and methods of use

    Expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 11389663

    Laser assisted wound healing protocol and system

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 10793564

    Amino acid compounds and methods of use

    Expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 10696672

    Amino acid compounds and methods of use

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 10604520

    N-acyl amino acid compounds and methods of use

    Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 10286036

    Protocol for treatment of lupus nephritis

    Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 8586055

    DNA immunization protocols

    Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is protocol?

protocol is an FDA-listed pharmaceutical active ingredient.